Phase | Pre-OP day1 | OP day1 | Post-OP day 1–71 |
---|---|---|---|
Study-day | -1 | 0 | 1–7 |
Medical history | X | ||
Physical examination | X | ||
Inclusion/exclusion criteria | X | ||
Karnowsky index | X | ||
Patient information | X | ||
Patient informed consent | X | ||
Concomitant medication | X | X | |
Documentation of surgery (OPS code) | X | ||
Clinical outcome | |||
Bilioma, pleural effusion, pneumonia, wound infection, peritonitis, UTI, sepsis | X | ||
Safety and Tolerance | |||
Adverse events (AE) | X | X | |
Liver | |||
Integrity: AST, AP, GGT, ALT, LDH, GSH | X | X | X |
Synthesis: CE, Chol, TP, PT, PTT albumin, CRP | X | X | X |
Elimination: Bilirubin | X | X | X |
Kidney | |||
Crea (blood), Na, K, Ca, Cl | X | X | X |
Urea-N. | X | X | X |
Crea (urine) for Crea-Clearance | X | X | |
Substrates, metabolites, cytokines | |||
Glucose, TG, lactate, IL-6, melatonin2 | X | X | X |
Hematology | |||
Hb, Hc, Thr, Leuko, Ery | X | X | X |